And Commodore Capital now owns 5.2% of $TYRA. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Every day, we sift through the filings to spot where the real conviction lies — cutting through the noise to highlight the most meaningful insider moves. Here's what stood out today: 📌 Keros Therapeutics $KROS – Madison Avenue Partners filed an original 13G reporting an initial stake of 6.40 %, jumping straight onto the cap table of this rare‑disease biotech. 📌 Tyra Biosciences $TYRA – Commodore Capital unveiled a new 5.20% stake in the precision‑oncology up‑and‑comer, another fresh biotech bet. Here's The Hot Corner, with data from May 14, 2025: |
Click the table to enlarge it. |
📌 Rep. Kelly Morrison's Tech Dips – Rep. Morrison bought $15,000 to $50,000 slices of Broadcom $AVGO and Meta $META, adding more Capitol Hill cash to semis and social media. 📌 Rep. Jonathan Jackson's Barbell Pair – Rep. Jackson grabbed $15,000 to $50,000 in Eli Lilly $LLY for steady pharma exposure, and $50 ,000 to $100,000 in Netflix $NFLX for growth punch. | Join Hot Corner Insider today and get actionable trade ideas, weekly live video and a monthly special report. Click here! | The Hot Corner Insider Here's what's happening with The Hot Corner Insider: - We get together on Wednesdays for the Hot Corner Insider Weekly Strategy Session. And we compile the recordings from each and every one in the Strategy Session Archive.
- Note that all actionable setups we discuss in The Hot Corner Insider are compiled on the Trade Ideas page.
And please reach out if you have any questions. |
| |
Alfonso Depablos | Senior Analyst, All Star Charts |
|
|
Stock Market Media emails are a financial publication of general circulation and only offers impersonal advice, not tailored to individual needs of a specific client or group. Any comments or statements made herein do not necessarily reflect those of Stock Market Media LLC or its affiliates (collectively, "Stock Market Media") and do not constitute buy or sell recommendations. Unless specifically indicated, this message is not an official confirmation of any transaction. The contents of any email communications to or from Stock Market Media may be monitored or reviewed at Stock Market Media's discretion. Stock Market Media accepts no responsibility for any loss or damage arising in any way from the use of this transmission and any attachments; it is the responsibility of the recipient to ensure that they are virus free. If you reply to this email, please note that we are a public investor and do not want any material non-public information. We do not agree to keep confidential any information you provide and do not agree to any restrictions on our trading activity, except pursuant to a written confidentiality agreement executed by Stock Market Media. |
Want to change how you receive these emails? You can manage your preferences here unsubscribe . © 2025 Stock Market Media |
|
|
|